ClinicalTrials.govpublic full text
A Study in Patients With Fabry Disease Who Are on Chronic Hemodialysis Therapy for Treatment of End-stage Renal Insufficiency.
fabry disease, agalsidase beta, alpha galactosidase a, agal, rh agal, fabry, gl3, fabrazyme, dialysis, hemodialysis, interventional, phase4
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 871384
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.